We have located links that may give you full text access.
Historical Article
Journal Article
History of promyelocytic leukaemia.
Leukemia 1994
The first reports on promyelocytic leukaemia came from Norway and France in 1957. Little by little, acute promyelocytic leukaemia acquired its rightful place in nosology as a hyperacute, invariable and rapidly fatal disease. In 1973, a high frequency of complete remissions induced by strong doses of daunorubicin and an acceptable frequency of true recovery, was demonstrated. After these preliminary events, the history of promyelocytic leukaemia was that of an important discovery: the first remissions of human acute leukaemia were obtained by cell differentiation, as all-trans retinoic acid induces complete remission of acute promyelocytic leukaemia in nearly all cases. The consequences of the discovery are discussed. For the long or middle term, we can hope for improved understanding of the action of retinoic acid, and possibly the preparation of new compounds with longer efficiency.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app